accès aux groupes de discussion, consultation et publication d'articles, recherche de "newsgroups"...
membres, identifiez-vous
é-mail Mot de passe
nouveau ? mot de passe oublié ?
Chargement... Chargement en cours...

Groupes français belges canadiens suisses internationaux Nétiquette
Échangez opinions et commentaires dans les forums de discussion.

Recent review articles about prostate cancer (InTextoResearch)

 [  Nouvelle Discussion Nouvelle discussion  |  Répondre au groupe Répondre au groupe  |  be.science ] 

Retour : Accueil du site be science  


  Sujet:   Recent review articles about prostate cancer (InTextoResearch)  
 De: scimed...@mail.com
 Groupes: be.science
 Organisation: http://groups.google.com
 Date: 01. Nov 2007, 12:09:32
InTextoResearch, agence d'information scientifique

InTextoResearch vous informe sur les dernières parutions d'articles
de
revue sur le cancer de la prostate (1er novembre 2007):

Current status of tissue kallikrein inhibitors: importance in cancer.
Bhoola KD, Misso NL, Naran A, Thompson PJ..
Curr Opin Investig Drugs. 2007 Jun;8(6):462-8..

Tissue kallikrein proteolytic cascade pathways in normal physiology
and cancer.
Pampalakis G, Sotiropoulou G.
Biochim Biophys Acta. 2007 Sep;1776(1):22-31.

Bone marrow stromal cells promote growth and survival of prostate
cancer cells.
Cross NA, Papageorgiou M, Eaton CL.
Biochem Soc Trans. 2007 Aug;35(Pt 4):698-700.

Cathepsin K in the bone microenvironment: link between obesity and
prostate cancer?
Podgorski I, Linebaugh BE, Sloane BF.
Biochem Soc Trans. 2007 Aug;35(Pt 4):701-3.

Pten inactivation and the emergence of androgen-independent prostate
cancer.
Shen MM, Abate-Shen C.
Cancer Res. 2007 Jul 15;67(14):6535-8.

Cryotherapy for localised prostate cancer.
Shelley M, Wilt TJ, Coles B, Mason MD.
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005010.

Chemoprevention of prostate cancer: agents and study designs.
Thompson IM.
J Urol. 2007 Sep;178(3 Pt 2):S9-S13.

Bone directed therapies for prostate cancer.
Bradley DA, Hussain M, Dipaola RS, Kantoff P.
J Urol. 2007 Sep;178(3 Pt 2):S42-8.

Progensa PCA3 test for prostate cancer detection.
de la Taille A.
Expert Rev Mol Diagn. 2007 Sep;7(5):491-7.

Imaging in oncology from the University of Texas M. D. Anderson Cancer
Center: diagnosis, staging, and surveillance of prostate cancer.
Kundra V, Silverman PM, Matin SF, Choi H.
AJR Am J Roentgenol. 2007 Oct;189(4):830-44.

Cost analysis of screening for, diagnosing, and staging prostate
cancer based on a systematic review of published studies.
Ekwueme DU, Stroud LA, Chen Y.
Prev Chronic Dis. 2007 Oct;4(4):A100.

Rising prostate-specific antigen after primary treatment of prostate
cancer: sequential hormone manipulation.
Schmid HP, Keuler FU, Altwein JE.
Urol Int. 2007;79(2):95-104.

Prostate biopsy strategies.
Presti JC Jr.
Nat Clin Pract Urol. 2007 Sep;4(9):505-11.

The androgen receptor in prostate cancer: therapy target in search of
an integrated diagnostic test.
Ross JS.
Adv Anat Pathol. 2007 Sep;14(5):353-7.

Molecular profiling and genomic microarrays in prostate cancer.
Golias Ch, Charalabopoulos A, Stagikas D, Giannakopoulos X, Peschos D,
Batistatou A, Sofikitis N, Charalabopoulos K.
Exp Oncol. 2007 Jun;29(2):82-4.

Immunotherapy for prostate cancer using antigen-loaded antigen-
presenting cells: APC8015 (Provenge).
Harzstark AL, Small EJ.
Expert Opin Biol Ther. 2007 Aug;7(8):1275-80.

Update on anti-CTLA-4 antibodies in clinical trials.
Langer LF, Clay TM, Morse MA.
Expert Opin Biol Ther. 2007 Aug;7(8):1245-56.

Patient selection, cancer control, and complications after salvage
local therapy for postradiation prostate-specific antigen failure: a
systematic review of the literature.
Nguyen PL, D'Amico AV, Lee AK, Suh WW.
Cancer. 2007 Oct 1;110(7):1417-28.

Management of prostate cancer recurrences after radiation therapy-
brachytherapy as a salvage option.
Allen GW, Howard AR, Jarrard DF, Ritter MA.
Cancer. 2007 Oct 1;110(7):1405-16.

Prostatic intraepithelial neoplasia: recent advances.
Ayala AG, Ro JY.
Arch Pathol Lab Med. 2007 Aug;131(8):1257-66.

Immunotherapy for prostate cancer - recent progress in clinical
trials.
Kipp RT, McNeel DG.
Clin Adv Hematol Oncol. 2007 Jun;5(6):465-74, 477-9.

Stem cells in prostate cancer initiation and progression.
Lawson DA, Witte ON.
J Clin Invest. 2007 Aug;117(8):2044-50.

Prostate specific antigen only androgen independent prostate cancer:
natural history, challenges in management and clinical trial design.
Ryan CJ, Beer TM.
J Urol. 2007 Sep;178(3 Pt 2):S25-9.

Assessing and treating patients with increasing prostate specific
antigen following radical prostatectomy.
Sandler HM, Eisenberger MA.
J Urol. 2007 Sep;178(3 Pt 2):S20-4.

(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimed...@mail.com)


DateSujet  Auteur
01.01.
o 
Groups Explorer contact votre avis comment ça marche? rechercher un groupe suggérer un groupe abuse accueil du site   Imprimer cette page   Envoyer cette page à un(e) ami(e)
Usenet Gratuit